Home 禄 Business 禄 Manufacturing
R&D center for animal vaccine
March 13, 2012, Tuesday
|
Print Edition
Print Edition
GERMAN drugmaker Boehringer Ingelheim yesterday said it will invest 12 million euros (US$15.7 million) to set up its Asian Veterinary Research & Development Center in Shanghai to boost animal vaccine business.
The research facility will be located in Zhangjiang High-Tech Park and will focus on innovative vaccines targeted at specific diseases in swine and poultry.
It is the first animal health R&D facility set up by a global drug firm in China, and it's the third one for the company outside Germany and the United States.
(Cathy Ding)
The research facility will be located in Zhangjiang High-Tech Park and will focus on innovative vaccines targeted at specific diseases in swine and poultry.
It is the first animal health R&D facility set up by a global drug firm in China, and it's the third one for the company outside Germany and the United States.
(Cathy Ding)
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
